Thermo Fisher Scientific | TMO - Current Assets


Thermo Fisher Scientific reported $22.32B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 1.85B 178M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
General Electric Aerospace USD 39.7B 664M Jun/2026
Henry Schein USD 4.5B 32M Mar/2026
Illumina USD 2.74B 551M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Laboratory Of America USD 4.56B 538.3M Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
Olympus JPY 706.31B 53.66B Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Quest Diagnostics USD 2.57B 188M Mar/2026
Repligen USD 1.16B 23.98M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Veracyte USD 522.17M 33.8M Mar/2026
Waters USD 3.72B 1.73B Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026